US2017321230A1PendingUtilityA1
Diterpene Synthases and Method for Producing Diterpenoids
Est. expiryNov 21, 2031(~5.3 yrs left)· nominal 20-yr term from priority
C12N 15/70C07D 307/92C12N 9/88C12P 7/02C12P 15/00C12N 15/52C12Y 402/03032C12Y 402/03018C12Y 402/03C12N 1/20C07D 307/77C12N 15/81C12N 1/16
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are diterpene synthases (diTPS) and methods for producing diterpenoids. Also provided herein are nucleic acid sequences encoding diTPS, diTPS amino acid sequences, diTPS proteins, vectors, cells, transgenic organisms, uses, compositions, methods, processes, and kits thereof.
Claims
exact text as granted — not AI-modified1 . An isolated cis-abienol synthase (CAS) polypeptide selected from among:
a) the polypeptide whose sequence is set forth in one of SEQ ID NOS:7, 50 and 55; b) an active fragment of the polypeptide of a); and c) a polypeptide having a sequence of amino acids that has at least 85%, 90% or 95% sequence identity with a polypeptide of a) or b), wherein: the polypeptide or active fragment catalyzes the formation of cis-abienol from geranylgeranyl diphosphate (GGPP).
2 . The polypeptide of claim 1 that has a sequence of amino acids that has at least 95% sequence identity with a polypeptide of a) or b).
3 . The polypeptide of claim 1 that comprises the sequence of amino acids set forth in one of SEQ ID NOS:7, 50 and 55 or an active fragment thereof.
4 . The polypeptide of claim 1 that consists of the sequence of amino acids set forth in one of SEQ ID NOS:7, 50 and 55 or an active fragment thereof.
5 . The isolated polypeptide of claim 1 , wherein the isolated polypeptide is an active fragment that is a pseudomature form.
6 . The isolated polypeptide of claim 5 , wherein the polypeptide has the sequence of amino acid residues set forth in SEQ ID NO:50 or 55, or a sequence that has at least 95% sequence identity with SEQ ID NO:50 or 55.
7 . An isolated nucleic acid molecule, comprising a sequence of nucleotides encoding a cis-abienol synthase (CAS) polypeptide or active fragment thereof having a sequence of amino acids that has at least 85% or 90% sequence identity with a polypeptide whose sequence is set forth in one of SEQ ID NOS:7, 50 and 55 or a catalytically active fragment thereof, wherein:
the encoded polypeptide or active fragment catalyzes the formation of cis-abienol from geranylgeranyl diphosphate (GGPP); and the isolated nucleic acid molecule is cDNA.
8 . The isolated nucleic acid molecule of claim 7 , wherein the active fragment is a pseudomature form.
9 . The isolated nucleic acid molecule of claim 7 , comprising a sequence of nucleotides that has at least 85% or 90% sequence identity to the sequence of nucleotides set forth in one of SEQ ID NOS:8, 54 and 56 or the complement thereof, wherein the isolated nucleic acid molecule encodes a polypeptide that catalyzes the formation of cis-abienol from geranylgeranyl diphosphate (GGPP) or an active fragment of the polypeptide.
10 . A vector, comprising the nucleic acid molecule of claim 7 .
11 . A host cell, comprising a nucleic acid molecule encoding a cis-abienol synthase (CAS) polypeptide or active fragment thereof having a sequence of amino acids that has at least 85% or 90% sequence identity with a polypeptide whose sequence is set forth in one of SEQ ID NOS:7, 50 and 55 or a catalytically active fragment thereof, wherein:
the encoded polypeptide or active fragment catalyzes the formation of cis-abienol from geranylgeranyl diphosphate (GGPP); and the encoded cis-abienol synthase is heterologous to the host cell.
12 . The host cell of claim 11 that is a prokaryotic or eukaryotic host cell.
13 . The host cell of claim 11 , selected from among a bacterial, fungal, plant, insect, amphibian and animal cell.
14 . The host cell of claim 11 that is an E. coli cell or a yeast cell.
15 . The host cell of claim 11 that produces GGPP.
16 . A method of producing cis-abienol, comprising:
i) contacting (E,E,E)-geranylgeranyl diphosphate (GGPP) with a cis-abienol synthase (CAS) polypeptide encoded by the nucleic acid molecule of claim 7 under conditions effective to produce cis-abienol, wherein: contacting is effected with an isolated CAS polypeptide, or contacting is effected in a host cell comprising the nucleic acid molecule, and the nucleic acid molecule is heterologous to the host cell; and ii) optionally, isolating the cis-abienol produced in step i).
17 . The method of claim 16 , wherein the step of contacting (E,E,E)-geranylgeranyl diphosphate (GGPP) with the cis-abienol synthase (CAS) polypeptide is effected in vitro.
18 . The method of claim 16 , comprising isolating the cis-abienol.
19 . The method of claim 18 , further comprising converting the cis-abienol to (−)-ambroxide.
20 . The method of claim 19 , comprising isolating the ambroxide.
21 . The method of claim 16 , wherein the step of contacting (E,E,E)-geranylgeranyl diphosphate (GGPP) with the cis-abienol synthase (CAS) polypeptide is effected in vivo.Join the waitlist — get patent alerts
Track US2017321230A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.